Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA |
|---|
| Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
MC MCK MCKESSON CORP FY ended Apr 30, 2026 | $899.03 | $104.82B | $171.62B | $403.43B | $6.65B | $4.76B | 23.42x | 0.26x | 24.43x |
WB WBA Walgreens Boots Alliance, Inc. FY ended Oct 08, 2024 | — | — | — | $147.66B | -$4.45B | -$8.64B | — | — | — |
CV CVS CVS HEALTH Corp FY ended Feb 04, 2026 | $93.56 | $119.66B | $250.64B | $402.07B | $9.41B | $1.77B | 67.31x | 0.30x | 20.21x |
HS HSIC HENRY SCHEIN INC FY ended Feb 17, 2026 | $89.85 | $10.01B | -$27.40B | $13.18B | $955.00M | $398.00M | 27.48x | 0.76x | -24.78x |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 3.44x | 3/4 | -$33.74B | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 0.44x | 3/4 | $111.61B | $479.89 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 39.40x | 3/4 | $67.54B | $290.39 | Included in the active peer mix. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
MC MCK MCKESSON CORP FY ended Apr 30, 2026 | $899.03 | $104.82B | $171.62B | $403.43B | $6.65B | $4.76B | 23.42x | 0.26x | 24.43x |
WB WBA Walgreens Boots Alliance, Inc. FY ended Oct 08, 2024 | — | — | — | $147.66B | -$4.45B | -$8.64B | — | — | — |
CV CVS CVS HEALTH Corp FY ended Feb 04, 2026 | $93.56 | $119.66B | $250.64B | $402.07B | $9.41B | $1.77B | 67.31x | 0.30x | 20.21x |
HS HSIC HENRY SCHEIN INC FY ended Feb 17, 2026 | $89.85 | $10.01B | -$27.40B | $13.18B | $955.00M | $398.00M | 27.48x | 0.76x | -24.78x |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 3.44x | 3/4 | -$33.74B | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 0.44x | 3/4 | $111.61B | $479.89 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 39.40x | 3/4 | $67.54B | $290.39 | Included in the active peer mix. |